Iradimed (NASDAQ:IRMD) & Encision (NASDAQ:ECIA) Head to Head Survey

Encision (OTCMKTS:ECIA) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for Encision and Iradimed, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Encision 0 0 0 0 N/A
Iradimed 0 0 0 0 N/A

Profitability

This table compares Encision and Iradimed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Encision -3.32% -11.79% -6.67%
Iradimed 25.01% 18.95% 15.65%

Earnings & Valuation

This table compares Encision and Iradimed’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Encision $8.80 million 0.74 -$240,000.00 N/A N/A
Iradimed $38.52 million 7.94 $9.63 million $0.78 34.15

Iradimed has higher revenue and earnings than Encision.

Insider and Institutional Ownership

25.8% of Iradimed shares are held by institutional investors. 35.7% of Encision shares are held by company insiders. Comparatively, 56.8% of Iradimed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk and Volatility

Encision has a beta of -0.52, indicating that its stock price is 152% less volatile than the S&P 500. Comparatively, Iradimed has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500.

Summary

Iradimed beats Encision on 10 of the 10 factors compared between the two stocks.

About Encision

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The company's AEM instruments product line includes a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also provides various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; and AEM Burn Protection Cable, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was founded in 1991 and is based in Boulder, Colorado.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Receive News & Ratings for Encision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision and related companies with MarketBeat.com's FREE daily email newsletter.